Head-to-head · WeighScore
Edessa vs Roboclinic
By GLP-1 ScorecardUpdated
Score comparison
Edessa has the higher recorded score — 70.8/100 to 65.3/100.
Edessa grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Clean three-rung tables one click in, behind a homepage whose three cards all quote six-month rungs and whose cheapest belongs to a different drug.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Edessa | Roboclinic |
|---|---|---|
| WeighScore | 70.8/100 | 65.3/100 |
| Grade | C | C |
| Site position | #112 | #249 |
| Semaglutide | $179/mo month-to-month injectable ($135 only on a 6-month prepay) | $179/mo (12-month plan, compounded) |
| Tirzepatide | $239/mo month-to-month ($209 only on a 6-month prepay) | $299/mo (12-month plan, compounded) |
| Coverage | Not publicly listed | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #112 · C
Strengths
- Each product page carries a plain three-rung table, so the commitment behind every figure is visible
- "Same price, every dose" is printed on each product page
- Names its operating entity and a full street address in Las Vegas, Nevada
- All-inclusive: provider consultation, medication, free expedited shipping, ongoing check-ins and 24/7 clinical support, and HSA and FSA eligible
- An oral tablet sits beside the two injections
What to consider
- The homepage leads with "Start for just $135", a six-month prepay on the semaglutide injection; month-to-month tirzepatide is $239
- All three homepage cards quote the six-month rung, so the real monthly rates appear only after a click
- Its Terms give two corporate forms for the same company in one clause — "Edessa Group, LLC, a Nevada corporation"
- "Join 100,000+ successful GLP-1 patients" carries no source, and the money-back guarantee's terms are on no marketing page
- No lab or monitoring protocol is published
Site position #249 · C
Strengths
- Compounded semaglutide from $179/mo and tirzepatide from $299/mo on 12-month plans
- One all-in price bundles the provider consult, prescription, and delivery
- Offers both injectable and oral (tablet) compounded semaglutide
- 'Same price, every dose' means your cost does not rise as the dose increases
- AI-first intake with board-certified provider review; no insurance necessary
What to consider
- Lowest rates require a 12-month plan; month-to-month runs $299/mo (semaglutide) to $399/mo (tirzepatide)
- Individual compounding pharmacies are not named; fulfillment is routed through OpenLoop Health
- No published per-state list; site claims 'all 50 states, restrictions apply' and gates doctor review by region
- Refunds limited to your most recent billing cycle; none for used or partially used periods
- Operated by BrickFi, Inc., a newer brand with limited independent track record
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.